why choose us

First received: May 03, 2023

Clinical Trial: Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alopecia Areata

Study Type: INTERVENTIONAL


Official Title: Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata

Brief Summary: Introduction Alopecia areata (AA) is a complex inflammatory disease characterized by cellular infiltration of T- lymphocytes targeting hair follicles, disrupting the anagen phase, with spontaneous remission, recurrence, and exacerbation, making it very unpredictable and emotionally disturbing .It affects nearly 1-2% of the general population with a lifetime risk of 2%, The onset of AA might be at any age; however, most patients develop the disease before 40 years of age .Early-onset AA (a mean age of onset at 5-10…

Read more